Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Tymora Analytical Operations

Tymora Analytical Operations
2010 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$2.87M LATEST DEAL AMOUNT
4 INVESTORS
Description

Provider of new research products and reagents to research and development organizations within the life sciences market. The company has developed a set of novel laboratory technologies for the analysis of protein phosphorylation in the field of life sciences and proteomics.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 3495 Kent Avenue
  • Suite E400
  • West Lafayette, IN 47906
  • United States

+1 (765) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Tymora Analytical Operations’s full profile, request a free trial.

Tymora Analytical Operations Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Jan-2016 $2.87M 0000 Completed Generating Revenue
1. Accelerator/Incubator 10-Mar-2015 0000 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Tymora Analytical Operations Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
National Institutes of Health Government 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Purdue Research Foundation Limited Partner Minority 000 0000 000000 0

Tymora Analytical Operations Executive Team (2)

Name Title Board
Seat
Contact
Info
Anton Iliuk Ph.D Co-Founder, President & Chief Technology Officer
W. Andy Tao Ph.D Co-Founder & Chief Scientific Officer